Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Zhu, Shengyun  [Clear All Filters]
Journal Article
Zhu S, Xu K, Li S, Yu X, Liu Y, Zhang Q, Zeng L, Xu K, Fu C. Assessment of intestinal status in MPL mutant myeloproliferative neoplasms mice model. Int Immunopharmacol. 2023;125(Pt A):111091.
Zhu S, Li H, Liang J, Lv C, Zhao K, Niu M, Li Z, Zeng L, Xu K. Assessment of oral ciprofloxacin impaired gut barrier integrity on gut bacteria in mice. Int Immunopharmacol. 2020;83:106460.
Chen W, Su GZ, Xu Y, Guo W, Bhansali R, Pan B, Kong QL, Cheng H, Cao J, Qi K, et al. Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance. Int Immunopharmacol. 2021;94:107503.
Zhao K, Ruan S, Tian Y, Zhao D, Chen C, Pan B, Yan Z, Yin L, Zhu S, Xu K. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation. Int Immunopharmacol. 2016;39:383-388.
Zhong X, Zhu F, Qiao J, Zhao K, Zhu S, Zeng L, Chen X, Xu K. The impact of P2X7 receptor antagonist, brilliant blue G on graft-versus-host disease in mice after allogeneic hematopoietic stem cell transplantation. Cell Immunol. 2016.
Yang C, Shao T, Zhang H, Zhang N, Shi X, Liu X, Yao Y, Xu L, Zhu S, Cao J, et al. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy. J Transl Med. 2018;16(1):267.